期刊文献+

5-氮杂-2'-脱氧胞苷对多药耐药MCF-7/ADR和KBV/200细胞增殖及细胞周期影响作用机制的研究 被引量:1

The effects of 5-aza-2’- deoxyc ytidine on proliferation and cell c ycle of MCF-7/ADR cells and KBV/200 cells and their mechanism
原文传递
导出
摘要 目的:探讨5-氮杂-2'-脱氧胞苷(5-aza-2'-deoxycytidine,5-Aza-dC)对肿瘤多药耐药细胞生长抑制率、细胞周期的影响及可能的作用机制。方法:采用MTT法检测5-Aza-dC对人乳腺癌耐药细胞株MCF-7/ADR、口腔表皮癌多药耐药细胞KBV/200及其相应的亲本敏感MCF-7和KB细胞的生长抑制率;FCM法检测不同浓度5-Aza-dC(1、5和10μmol/L)作用72h及5-Aza-dC(10μmol/L)作用24、48和72h后,各细胞周期分布的变化;分别采用实时荧光定量-PCR及蛋白质印迹法检测细胞周期相关蛋白cyclin A、cyclin E和p21waf1/cip1mRNA及蛋白的表达情况。结果:5-Aza-dC对耐药细胞株MCF-7/ADR及KBV/200均呈现明显的生长抑制作用,细胞周期被阻滞在G2/M期,并呈时间及剂量依赖性;细胞周期相关蛋白cyclin A、cyclin E和p21waf1/cip1mRNA及蛋白的表达均上调。结论:5-Aza-dC可以通过使MCF-7/ADR及KBV/200细胞的细胞周期被阻滞在G2/M期,从而抑制肿瘤多药耐药细胞的增殖;其作用机制可能与上调细胞周期相关蛋白cyclin A、cyclin E和p21waf1/cip1的表达有关。 Objective: To investigate the effect of 5-Aza-dC (5-aza-2’-deoxycytidine) on cell cycle of multidrug resistant cells and its mechanism. Methods: Inhibitory effects of 5-Aza-dC on proliferation of breast cancer MCF-7/ADR cells and oral epidermoid carcinoma KBV/200 cells were detected by MTT method. The changes of cell cycle distribution were examined by flow cytometry when the cells were treated with 5-Aza-dC at different concentrations for 72 h or treated with the same concentration of 5-Aza-dC (10 μmol/L) for different time. The expression levels of cyclin A, cyclin E and p21waf1/cip1 mRNAs and proteins were detected by real-time fluorogenic quantitative-PCR and Western blotting, respectively. Results: The proliferation of MCF-7/ADR and KBV/200 cells was suppressed significantly after 5-Aza-dC treatment. The cell cycle was arrested at G2/M phase in dose- and time-dependent manners. The expression levels of cyclin A, cyclin E and p21waf1/cip1 mRNAs and proteins were elevated. Conclusion: The cell cycle of MCF-7/ADR and KBV/200 cells can be arrested at G2/M phase which consequently results in the inhibition of proliferation of multidrug resistant cells induced by 5-Aza-dC. The molecular mechanisms may be related with up-regulation of expressions of cyclin A, cyclin E and p21 waf1/cip1 mRNAs and proteins.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第11期874-879,共6页 Tumor
基金 国家自然科学基金资助项目(编号:30971291) 国家自然科学基金资助项目(编号:30873091)
关键词 乳腺肿瘤 口腔肿瘤 脱氧胞苷 细胞抑制剂 细胞周期蛋白类 Breast neoplasms Mouth neoplasms Deoxycytidine Cytostatic agents Cyclins
  • 相关文献

参考文献13

  • 1YANG A S, DOSHI K D, CHOI S W, et al. DNA methylation changes after 5-aza-2'- deoxycytidine therapy in patients with leukemia[J]. Cancer Res, 2006, 66(10): 5495-5503.
  • 2黄明主,李杰.基因技术在逆转肿瘤细胞多药耐药性上的应用[J].肿瘤,2004,24(6):608-610. 被引量:7
  • 3DASKALAKIS M, NGUYEN T, NGUYEN C, et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment [J]. Blood, 2002, 100(8): 2957-2964.
  • 4MOMPARLER R L. Epigenetic therapy of cancer with 5-Aza-2'-deoxycytidine (decitabine)[J].Semin Oncol, 2005, 32(5): 443-451.
  • 5XlONG H, CHEN Z F, LIANG Q C, et al. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signaling[J].J Cell Mol Med, 2009, 13(9B):3668-3679.
  • 6MIRZA S, SHARMA G, PANDYA P, et al. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of breast cancer cells toanticancer agents[J]. Mol Cell Biochem, 342(1-2):101-109.
  • 7MOMPARLER R L, ELIOPOULOS N, AYOUB J. Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy[J]. Adv Exp Med BioL, 2000, 465:433-446.
  • 8ZHANG X, YASHIRO M, OHIRA M, et al. Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma[J]. Cancer Science, 2006, 97(9):938-944.
  • 9MOMPARLER R L. Pharmacology of 5-aza-2'- deoxycytidine(decitabine)[J]. Semin Hematol, 2005, 42(3 Suppl 2):S9-S16.
  • 10SZAKACS G, PATERSON J K, LUDWIG J A, et al. Targeting multidrug resistance in cance [J]. Nat Rev Drug Discov, 2006, 5(3):219-234.

共引文献6

同被引文献12

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CACancer J Clin, 2010,60(5) :277-300.
  • 2Verdecchia A, Francisci S, Brenner H, et al. Recent cancer sur- vival in Europe: a 2000--02 period analysis of EUROCARE-4 data[J]. Lancet Oncol, 2007, 8(9) :784-796.
  • 3Liu WK, Ling YH, Cheung FW, et al. Stellettin A induces en- doplasmic reticulum stress in murine B16 melanoma ceils[ J]. J Nat Prod, 2012, 75(4) :586-590.
  • 4Tang SA, Zhou Q, Guo WZ, et al. In vitro antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cells [ J ]. Mar Drugs, 2014, 12(7) :4200-4213.
  • 5Viau CM, Moura DJ, Facundo VA, et al. The natural triterpene 313, 613, 1613-trihydroxy-lup-20 (29)-ene obtained from the flowers of Combretum leprosuminduces apoptosis in MCF-7 breast cancer cells[ J]. BMC Complement Altem Med, 2014, 14:280.
  • 6Hsu YC, Chen MJ, Huang TY. Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45 in human brain malignant glioma (GBM) 8401 cells[ J/OL]. Cell Death Dis, 2014 [ 2014-07-301. http ://www. ncbi. nim. nih. gov/pubmed/24- 577085.
  • 7Minh PT, Lam do T, Tien NQ, et al. New schiartane-type triter- pene from Kadsura heteroclita and their cytotoxic activities [ J ]. Nat Prod Commun, 2014, 9(3) :373-374.
  • 8Liu Y, Bi T, Shen G, Li Z, et al. Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by sup- pression of EGFR/MMP-9 signaling pathway[ J/OL]. Cytotechn- ology, 2014 [ 2014-07-30 ]. http://www, ncbi. nlm. nih. gov! pubmed/25037728.
  • 9高默杰,徐忠伟,王凤梅,陈小义,呼文亮,徐瑞成.钠钾泵抑制剂通过调节细胞周期相关蛋白的生成介导肝癌HepG2细胞周期S期阻滞与凋亡[J].中国药理学通报,2010,26(4):452-456. 被引量:24
  • 10王丹云,刘佳,印明柱,李雪婷,娄阁,刘运铎,陈秀玮.白桦酯醇诱导宫颈癌HeLa细胞凋亡及作用机制的研究[J].肿瘤,2012,32(4):234-238. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部